Colorcon launches titanium dioxide-free film coating
Colorcon has introduced a new titanium dioxide-free film coating system for pharmaceutical tablets.
Photo © iStockphoto.com/victorhe2002
Colorcon (Harleysville, PA) has introduced a new titanium dioxide (TiO2)-free film coating system for pharmaceutical tablets, called Opadry. The system is based on polyvinyl alcohol.
“With uncertainty around the future of TiO2 use in pharmaceutical products marketed in the European Union, global pharmaceutical manufacturers are interested to formulate their products without the inclusion of TiO2,” said Annabel Bordmann, film coatings general manager for Colorcon, in a press release. “During the past 5 years, Colorcon scientists have been developing a portfolio of TiO2-free film coating products for different functionalities. This new formulation is not only TiO2-free but provides PVA-based coating benefits and good opacity at standard weight gain.”
“With Colorcon’s in-depth knowledge of materials, coating technology and regulatory needs, this new TiO2-free formulation is designed to provide the PVA-based film coating properties such as; great adhesion, easy and fast processing times combined with moisture protection, that formulators have appreciated for many years,” added Ali Rajabi-Siahboomi, PhD, Colorcon’s chief innovation officer.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
